Episode #14 - These hamsters have birthed billions for biotech
Aug 3, 2016 - 00:20:43
Radio and PodcastLive Radio & Podcasts
Science & Medicine
UPDATE: What happened at the FDA panel review of one Duchenne drug?
An FDA panel reviewed a drug for Duchenne muscular dystrophy called drisaperson on Tuesday. What it found is not encouraging. The Signal podcast takes a look at what happened and where things go from here.
About This Episode
UPDATE: What happened at the FDA panel review of one Duchenne drug? is an episode from Signal by Signal. An FDA panel reviewed a drug for Duchenne muscular dystrophy called drisaperson on Tuesday. What it found is not encouraging. The Signa...
Podcast
This episode belongs to Signal.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Nov 25, 2015, 00:08:23 long, audio available.
Related Episodes
Continue listening to more episodes from Signal.
Episode #13 - The superbugs are quietly amassing their forces -- and we're helping them
Jul 13, 2016 - 00:24:46
Episode #12 - Before you pop that Tylenol, listen to this podcast
Jun 15, 2016 - 00:25:37
Episode #10 - Cancer is a low-down, dirty gangster ninja
May 4, 2016 - 00:23:04
Episode #9 - What should you most fear? Sharks, killer snails or the flu?
Apr 18, 2016 - 00:23:09
SIgnal takes a mini-break for a special reason
Feb 11, 2016 - 00:03:07
Episode #6 - Choosing scientific sides in the fight against Alzheimer's
Jan 28, 2016 - 00:20:12
Questions About This Episode
What is UPDATE: What happened at the FDA panel review of one Duchenne drug? about?
An FDA panel reviewed a drug for Duchenne muscular dystrophy called drisaperson on Tuesday. What it found is not encouraging. The Signal podcast takes a look at what happened and where things go from here.
Where can I listen to UPDATE: What happened at the FDA panel review of one Duchenne drug??
You can listen to UPDATE: What happened at the FDA panel review of one Duchenne drug? online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is UPDATE: What happened at the FDA panel review of one Duchenne drug? from?
UPDATE: What happened at the FDA panel review of one Duchenne drug? is an episode from Signal by Signal.
How long is this episode?
This episode is 00:08:23 long.
When was this episode published?
This episode was published on Nov 25, 2015.
Can I save UPDATE: What happened at the FDA panel review of one Duchenne drug? for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Signal?
Yes. This page shows related episodes from Signal when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to UPDATE: What happened at the FDA panel review of one Duchenne drug??
You can listen to UPDATE: What happened at the FDA panel review of one Duchenne drug? on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
UPDATE: What happened at the FDA panel review of one Duchenne drug? is from Signal by Signal.
What are the episode details?
Published Nov 25, 2015 and 00:08:23 long